Sudo to sign joint A1 flu vaccine development with a US firm.
The agreement describes that Sudo develops the A1 flu vaccine by the use of MediVas' biopolymer technology, taking exclusive distributi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
